Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $18.0B |
| FY2017, ended Dec 31, 2017 | $28.2B |
| FY2018, ended Dec 31, 2018 | $26.8B |
| FY2019, ended Dec 31, 2019 | $44.5B |
| FY2020, ended Dec 31, 2020 | $54.3B |
| FY2021, ended Dec 31, 2021 | $72.3B |
| FY2022, ended Dec 31, 2022 | $51.0B |
| FY2023, ended Dec 31, 2023 | $71.3B |
| FY2024, ended Dec 31, 2024 | $85.2B |
| FY2025, ended Dec 31, 2025 | $90.6B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $78.3B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.60B |
| FY2017, ended Dec 31, 2017 | $4.20B |
| FY2018, ended Dec 31, 2018 | $4.44B |
| FY2019, ended Dec 31, 2019 | $4.83B |
| FY2020, ended Dec 31, 2020 | $5.37B |
| FY2021, ended Dec 31, 2021 | $6.22B |
| FY2022, ended Dec 31, 2022 | $5.47B |
| FY2023, ended Dec 31, 2023 | $5.92B |
| FY2024, ended Dec 31, 2024 | $7.09B |
| FY2025, ended Dec 31, 2025 | $7.72B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $8.18B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $267M | $1.14B |
| FY2017, ended Dec 31, 2017 | $1.00B | $664M |
| FY2018, ended Dec 31, 2018 | $1.31B | $1.37B |
| FY2019, ended Dec 31, 2019 | $1.42B | $1.61B |
| FY2020, ended Dec 31, 2020 | $1.78B | $2.04B |
| FY2021, ended Dec 31, 2021 | $2.21B | $1.87B |
| FY2022, ended Dec 31, 2022 | $1.37B | $1.19B |
| FY2023, ended Dec 31, 2023 | $1.61B | $1.88B |
| FY2024, ended Dec 31, 2024 | $2.06B | $2.52B |
| FY2025, ended Dec 31, 2025 | $2.46B | $2.58B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $2.88B | $2.98B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.05B |
| FY2017, ended Dec 31, 2017 | $1.07B |
| FY2018, ended Dec 31, 2018 | $1.69B |
| FY2019, ended Dec 31, 2019 | $1.83B |
| FY2020, ended Dec 31, 2020 | $2.60B |
| FY2021, ended Dec 31, 2021 | $1.81B |
| FY2022, ended Dec 31, 2022 | $1.77B |
| FY2023, ended Dec 31, 2023 | $2.13B |
| FY2024, ended Dec 31, 2024 | $2.41B |
| FY2025, ended Dec 31, 2025 | $2.38B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.51B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.36B |
| FY2017, ended Dec 31, 2017 | $5.54B |
| FY2018, ended Dec 31, 2018 | $5.68B |
| FY2019, ended Dec 31, 2019 | $5.58B |
| FY2020, ended Dec 31, 2020 | $6.42B |
| FY2021, ended Dec 31, 2021 | $7.41B |
| FY2022, ended Dec 31, 2022 | $7.39B |
| FY2023, ended Dec 31, 2023 | $7.00B |
| FY2024, ended Dec 31, 2024 | $7.43B |
| FY2025, ended Dec 31, 2025 | $6.99B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $6.91B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 9.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 191M |
| FY2017, ended Dec 31, 2017 | 191M |
| FY2018, ended Dec 31, 2018 | 191M |
| FY2019, ended Dec 31, 2019 | 187M |
| FY2020, ended Dec 31, 2020 | 187M |
| FY2021, ended Dec 31, 2021 | 185M |
| FY2022, ended Dec 31, 2022 | 183M |
| FY2023, ended Dec 31, 2023 | 183M |
| FY2024, ended Dec 31, 2024 | 180M |
| FY2025, ended Dec 31, 2025 | 177M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 172M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $739M | $98.1M | — |
| FY2017, ended Dec 31, 2017 | $200M | $123M | — |
| FY2018, ended Dec 31, 2018 | $203M | $130M | — |
| FY2019, ended Dec 31, 2019 | $991M | $136M | — |
| FY2020, ended Dec 31, 2020 | $503M | $154M | — |
| FY2021, ended Dec 31, 2021 | $750M | $175M | — |
| FY2022, ended Dec 31, 2022 | $983M | $169M | $44.0M |
| FY2023, ended Dec 31, 2023 | $490M | $193M | — |
| FY2024, ended Dec 31, 2024 | $1.29B | $220M | — |
| FY2025, ended Dec 31, 2025 | $1.61B | $232M | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $2.99B | $233M | — |
Valuation
At current price- Market Cap
- $81.7B
- P/E
- 28.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 10.0×
- Price / Book
- 25.0×
- EV / EBITDA
- 21.0×
Growth
Trailing 12 months- Revenue (TTM)
- $8.18B
- Revenue Growth YoY
- 9.0%
- Revenue CAGR 3Y
- 12.2%
- Revenue CAGR 5Y
- 7.5%
- EPS Growth YoY
- 31.9%
- Net Income Growth YoY
- 28.5%
Profitability
Trailing 12 months- Gross Margin
- 74.6%
- Operating Margin
- 44.6%
- Net Margin
- 35.3%
- FCF Margin
- 36.4%
- Return on Equity
- 79.8%
Earnings
Trailing 12 months- Net Income
- $2.88B
- EPS (diluted)
- $16.39
- EBITDA
- $4.14B
- Operating Income
- $3.64B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $1.51B
- Total Debt
- $6.91B
- Net Debt
- $5.40B
- Total Assets
- $14.8B
- Total Liabilities
- $11.4B
- Shareholders' Equity
- $3.27B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.33B
- Capital Expenditure
- $352M
- Free Cash Flow
- $2.98B
Dividends and risk
Last 12 months- Dividend Yield
- 0.9%
- Dividend / Share
- $4.03
- Beta (5Y)
- 1.35
Every ratio is calculated from the company’s reported figures.